WeightWatchers CEO Sima Sistani talks TikTok, Telehealth Deal on GLP-1/Ozempic and Why She Took the Job

WeightWatchers CEO Sima Sistani talks TikTok,...

Up next

Survivors Speak Out: Taking On the ‘Epstein Class’

It’s been more than a month since the Justice Department released the latest tranche of files related to its investigation of Jeffrey Epstein — around 3 million in total — yet the fallout shows no sign of slowing down. The release almost certainly wouldn’t have happened if it wer ...  Show more

Friction Matters: Resistance Is a Feature, Not a Bug

Friction gets an bad rap, according Jennifer Vail. As a tribologist, she studies interacting surfaces in relative motion, and she’s worked on everything from aerospace materials to syringes to dog food. Her new book, Friction: A Biography, explores the science of rubbing surfaces ...  Show more

Recommended Episodes

The Big Business Behind Weight Loss Drugs
Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ...  Show more

WeightWatchers CEO Explains Why ‘We Got It Wrong’
Chasing Life

Long before WeightWatchers became a weight loss empire, the legacy dieting company started as a small support group in the 1960s. The company rose to popularity preaching a message of moderation and making healthy choices. But in what some call a surprising pivot, WeightWatchers ...  Show more

Is Ozempic Really A Weight Loss Wonder Drug?
The Quicky

You may have heard about a new miracle weight loss drug called Ozempic. Videos have been spreading online of users claiming insane weight loss in short periods of time. Even celebrities like Kim Kardashian have been accused of using it to slim down. There's just one problem...Oze ...  Show more

Those New Obesity Drugs Really Work–If You Can Afford Them
Big Take

Pharmaceutical companies and insurance providers are at odds over a new class of drugs that have proven quite effective at helping people living with obesity lose weight. Bloomberg’s Robert Langreth and Emma Court join this episode to share their reporting on recent advancements ...  Show more